Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahar Khan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oman Medical Journal|August 15, 2017
Influence of Eysenckian Personality Traits in Choice of Specialization by Young Omani DoctorsMohammed Al-Alawi, Hamed Al-Sinawi, Salim Al-Husseini, et al.
Bioorganic & Medicinal Chemistry|January 9, 2014
Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitorsMadiha Sahar Khan, Munawar Ali Munawar, Mohammad Ashraf, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2024
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline ConsortiumSahar Khan, Debra J Bergstrom, Julie Côté, et al.
Cancers|July 15, 2026
Toxicities of CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates in Multiple Myeloma: A Practical Approach to Risk Mitigation and ManagementSereen Hej-Ali, Kyle Banwell, Halima Mohamed, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 23, 2022
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?Sahar Khan, Donna Reece, Eshetu G Atenafu, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 15, 2023
Understanding equitable and affirming communication moments and relationship milestones during the intensive care unit journey: findings from stage 1 of a design thinking projectSalima Suleman, Jennifer M O'Brien, Cari McIlduff, et al.
Leukemia & Lymphoma|January 29, 2021
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myelomaSahar Khan, Richard LeBlanc, Martin Gyger, et al.
Leukemia Research|August 24, 2025
Pilot study: A prospective, real-world, feasibility study testing a decreased frequency paradigm in treatment free remission in chronic myeloid leukemiaSiri Ravipati, Waffa Bakheet, Indryas Woldie, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 18, 2025
Opportunities and threats to communication and relationships with patients and patients' loved ones along an intensive care unit journey: a qualitative journey mapping studySalima Suleman, Jennifer M O'Brien, Cari McIlduff, et al.
Critical Care Explorations|June 28, 2026
Patient- and Family-Centered Care, Communication, and Relationship Development Along a Technological Continuum in the ICU: A Scoping ReviewBrittany Benson, Mahour Taheri, Salima Suleman, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oman Medical Journal|August 15, 2017
Influence of Eysenckian Personality Traits in Choice of Specialization by Young Omani DoctorsMohammed Al-Alawi, Hamed Al-Sinawi, Salim Al-Husseini, et al.
Bioorganic & Medicinal Chemistry|January 9, 2014
Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitorsMadiha Sahar Khan, Munawar Ali Munawar, Mohammad Ashraf, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2024
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline ConsortiumSahar Khan, Debra J Bergstrom, Julie Côté, et al.
Cancers|July 15, 2026
Toxicities of CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates in Multiple Myeloma: A Practical Approach to Risk Mitigation and ManagementSereen Hej-Ali, Kyle Banwell, Halima Mohamed, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 23, 2022
Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?Sahar Khan, Donna Reece, Eshetu G Atenafu, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 15, 2023
Understanding equitable and affirming communication moments and relationship milestones during the intensive care unit journey: findings from stage 1 of a design thinking projectSalima Suleman, Jennifer M O'Brien, Cari McIlduff, et al.
Leukemia & Lymphoma|January 29, 2021
A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myelomaSahar Khan, Richard LeBlanc, Martin Gyger, et al.
Leukemia Research|August 24, 2025
Pilot study: A prospective, real-world, feasibility study testing a decreased frequency paradigm in treatment free remission in chronic myeloid leukemiaSiri Ravipati, Waffa Bakheet, Indryas Woldie, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 18, 2025
Opportunities and threats to communication and relationships with patients and patients' loved ones along an intensive care unit journey: a qualitative journey mapping studySalima Suleman, Jennifer M O'Brien, Cari McIlduff, et al.
Critical Care Explorations|June 28, 2026
Patient- and Family-Centered Care, Communication, and Relationship Development Along a Technological Continuum in the ICU: A Scoping ReviewBrittany Benson, Mahour Taheri, Salima Suleman, et al.
Pageof 3